Collectively, these data suggested that the METTL3-m6A-TNFR1-ATXN2 axis plays oncogenic roles in ESCC through MAPK and NF-κB signaling pathways. This evidence concerns the gene NFKB1 and esophageal squamous cell carcinoma.